- 2024-08-20 01:46抑制剂BAY1082439|BAY1082439|1375469-38-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:46抑制剂BAY 61-3606|BAY 61-3606|732983-37-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:46抑制剂BAY 61-3606|BAY 61-3606|732983-37-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:46抑制剂BAY 61-3606|BAY 61-3606|732983-37-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:46抑制剂Bay K 8644|Bay K 8644|71145-03-4|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:46抑制剂BAY 61-3606 dihydrochloride|BAY 61-3606 dihydrochloride|648903-57-5|Adamas life|≥98%（以实测数值为准）|BR|
- 2024-08-20 01:46抑制剂BAY 61-3606 dihydrochloride|BAY 61-3606 dihydrochloride|648903-57-5|Adamas life|≥98%（以实测数值为准）|BR|
- 2024-08-20 01:46抑制剂BAY 61-3606 dihydrochloride|BAY 61-3606 dihydrochloride|648903-57-5|Adamas life|≥98%（以实测数值为准）|BR|
- 2024-08-20 01:46抑制剂BAR501|BAR501|1632118-69-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:46抑制剂Barasertib-HQPA|Barasertib-HQPA|722544-51-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:46抑制剂Barasertib-HQPA|Barasertib-HQPA|722544-51-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:46抑制剂Barasertib-HQPA|Barasertib-HQPA|722544-51-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:46抑制剂BAR501|BAR501|1632118-69-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:46抑制剂BAR501|BAR501|1632118-69-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:46抑制剂Baloxavir|Baloxavir|1985605-59-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:46抑制剂Baloxavir|Baloxavir|1985605-59-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:46抑制剂Baloxavir marboxil|Baloxavir marboxil|1985606-14-1|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:46抑制剂Baloxavir marboxil|Baloxavir marboxil|1985606-14-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:46抑制剂Baloxavir marboxil|Baloxavir marboxil|1985606-14-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:46抑制剂Baloxavir|Baloxavir|1985605-59-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
